| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
| 04/13/2011 | CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists |
| 04/13/2011 | CN102015634A Pesticides |
| 04/13/2011 | CN102010410A Heterocyclic compound and organic light emitting device including same |
| 04/13/2011 | CN101448503B Piperidine and piperazine derivatives |
| 04/13/2011 | CN101420957B Therapeutic agent for inflammatory bowel disease |
| 04/13/2011 | CN101384549B Pyrrole derivative or salt thereof |
| 04/12/2011 | US7923566 Alternative process for the preparation of losartan |
| 04/12/2011 | US7923556 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 04/12/2011 | US7923555 Fused bicyclic mTor inhibitors |
| 04/12/2011 | US7923129 Carbazole derivative and organic light emitting device using the same |
| 04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 04/07/2011 | WO2011041634A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | WO2011041152A1 Novel compounds that are erk inhibitors |
| 04/07/2011 | WO2011039782A1 Processes for preparing imatinib and pharmaceutically acceptable salts thereof |
| 04/07/2011 | WO2011039735A2 Compounds with ddx3 inhibitory activity and uses thereof |
| 04/07/2011 | WO2011039528A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
| 04/07/2011 | WO2011039358A1 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 04/07/2011 | WO2011039353A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/07/2011 | WO2011039344A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
| 04/07/2011 | WO2011039130A1 New benzimidazole derivatives and their use as fxr agonists |
| 04/07/2011 | WO2010138720A9 Compounds and methods for chelating metals in aqueous solutions |
| 04/07/2011 | WO2010130900A3 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors |
| 04/07/2011 | WO2010129665A3 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
| 04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
| 04/07/2011 | US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules |
| 04/07/2011 | US20110082182 Therapeutic antiviral peptides |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082165 Pyrrolidine gpr40 modulators |
| 04/07/2011 | US20110082163 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 04/07/2011 | US20110082155 Novel 2-Pyridone Compounds |
| 04/07/2011 | US20110082153 Gamma secretase modulators |
| 04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
| 04/07/2011 | US20110082151 Sulfonylurea modulators of endothelin receptor |
| 04/07/2011 | US20110082146 Compositions and methods for inhibition of the jak pathway |
| 04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 04/07/2011 | US20110082143 Bicyclic Heteroaryl Compounds |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | CA2776351A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/07/2011 | CA2776294A1 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 04/07/2011 | CA2775418A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
| 04/07/2011 | CA2773618A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
| 04/07/2011 | CA2772815A1 New benzimidazole derivatives and their use as fxr agonists |
| 04/06/2011 | EP2305674A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 04/06/2011 | EP2305653A1 Therapeutic agent for chronic renal failure |
| 04/06/2011 | EP2305652A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/06/2011 | EP2305651A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/06/2011 | EP2305643A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/06/2011 | EP2305640A2 Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases |
| 04/06/2011 | EP2305250A1 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/06/2011 | EP2303890A2 Phosphatidylinositol 3 kinase inhibitors |
| 04/06/2011 | EP2303871A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 04/06/2011 | EP2303870A2 Process for preparation of candesartan cilexetil |
| 04/06/2011 | EP2303869A2 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives |
| 04/06/2011 | EP2303862A2 Wnt protein signalling inhibitors |
| 04/06/2011 | EP2303018A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 04/06/2011 | EP2125788B1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 04/06/2011 | EP1934174B1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/06/2011 | EP1814849B1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN1788003B Triazine compounds and their use in forming multidimensional libraries for affinity chromatography |
| 04/06/2011 | CN1649612B Induction method for cell differentiation |
| 04/06/2011 | CN102007122A Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 04/06/2011 | CN102007121A 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 04/06/2011 | CN102007120A Fungicide hydroximoyl-heterocycles derivatives |
| 04/06/2011 | CN102007118A Pyrrolidinone glucokinase activators |
| 04/06/2011 | CN102007116A Pyridazinone glucokinase activators |
| 04/06/2011 | CN102007115A Pyrimidylmethyl sulfonamide compounds |
| 04/06/2011 | CN102007106A 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 04/06/2011 | CN102007105A 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 04/06/2011 | CN102007102A Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 04/06/2011 | CN102006873A Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 04/06/2011 | CN102006870A Compounds and compositions as modulators of gpr119 activity |
| 04/06/2011 | CN102002038A Ligustrazine nitrogen (oxygen) heteroatom alkylation derivative as well as preparation method and application thereof |
| 04/06/2011 | CN102002036A Method for refining fasudil |
| 04/05/2011 | US7919654 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same |
| 04/05/2011 | US7919618 Preparing (3'-chloro-biphenyl-4-yl)-(1-pyrimidin-2-yl-piperidin-4-yl)-methanone, or a salt or solvate thereof by contacting (3'-chloro-biphenyl-4-yl)-piperidine-4-yl-methanone with 2-chloropyrimidine in base; cataysis using bis(triphenylphosphine)palladium(II) dichloride; nervous system disorders |
| 04/05/2011 | US7919617 Cytokine inhibitors |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919520 Inhibitors of tace |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919488 Therapeutic compounds |
| 04/05/2011 | US7919071 Contrast agent |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 03/31/2011 | WO2011038234A2 Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions |
| 03/31/2011 | WO2011038097A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011038086A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011036130A1 Indole derivatives as crac modulators |
| 03/31/2011 | WO2011036074A1 Aminoquinazoline compounds for combating invertebrate pests |
| 03/31/2011 | WO2011035355A1 Novel antimalarial 3-azabicyclo[3.2.2]nonane derivatives |
| 03/31/2011 | WO2011017299A3 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 03/31/2011 | WO2010132852A3 Protease inhibitors |
| 03/31/2011 | WO2010120112A3 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof |
| 03/31/2011 | WO2010120058A3 Novel cyanine compound for labelling biomolecules, and preparation method thereof |